In thyroid cancers, TGF-β decreases NIS expression in the invasive margins [16, 17] that could enable the cells to escape RAI ablation and lead to RAI-refractory metastatic lesions. This evidence concerns the gene TGFB1 and thyroid gland carcinoma.